Remicade

J&J’s move to cut Remicade price cost some big bucks, but guarded against Pfizer’s copycat
Endpoints
Tue, 01/23/18 - 09:00 pm
JNJ
Remicade
drug pricing
Pfizer
biosimilars
The 2018 biosimilar litigation landscape: A primer
BioPharma Dive
Sun, 12/17/17 - 11:35 am
biosimilars
FDA
Neupogen
Neulasta
Remicade
Epogen
Enbreal
Humira
Avastin
Herceptin
Pfizer Not Planning US Launch of its Second Remicade Biosimilar Approved by FDA
RAPS.org
Fri, 12/15/17 - 09:36 am
Pfizer
biosimilars
Remicade
Ixifi
Inflectra
JNJ
Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval
Yahoo/Reuters
Thu, 12/14/17 - 09:18 am
Pfizer
biosimilars
JNJ
Remicade
Ifixi
rheumatoid arthritis
Crohn's Disease
[forum discussion]Pfizer Jumps the Shark over Biosimilar Failure
Cafepharma Message Boards
Tue, 12/12/17 - 11:14 am
Pfizer
biosimilars
Inflectra
Remicade
JNJ
Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar
JD Supra
Thu, 12/7/17 - 09:07 am
Pfizer
JNJ
Remicade
biosimilars
anticompetitive practices
Celltrion
As Johnson & Johnson holds off U.S. biosims, Remicade's European market share falls to 50%: report
Fierce Pharma
Tue, 12/5/17 - 06:31 pm
JNJ
biosimilars
Remicade
Europe
anti-TNF
Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy
Yahoo/Reuters
Tue, 11/14/17 - 07:57 am
Janssen
Samsung Bioepis
Remicade
biosimilars
rheumatoid arthritis
Pfizer ready for a fight as biosimilar sales continue to lag
BioPharma Dive
Tue, 10/31/17 - 09:16 pm
Pfizer
biosimilars
Inflectra
Remicade
JNJ
J&J's Remicade stands firm against biosim competition in Q3
Fierce Pharma
Tue, 10/17/17 - 08:21 pm
JNJ
Remicade
biosimilars
[video+transcript]Is This How Drugmakers Will Kill Biosimilars?
Motley Fool
Tue, 10/3/17 - 11:40 am
biosimilars
Pfizer
JNJ
Inflectra
Remicade
Pfizer is falling short in a competitive market, Johnson & Johnson says as it hits back at Remicade biosimilar suit
Fierce Pharma
Tue, 09/26/17 - 09:39 pm
Pfizer
JNJ
Remicade
Inflectra
biosimilars
This squabble between two big drugmakers could have major implications for the U.S. health care system
Marketwatch
Thu, 09/21/17 - 08:36 am
JNJ
Pfizer
antitrust
biosimilars
Remicade
Inflectra
Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar
First Word Pharma
Wed, 09/20/17 - 11:03 am
Pfizer
JNJ
Janssen
Remicade
biosimilars
Inflectra
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Drug Channels
Wed, 09/20/17 - 09:05 am
drug pricing
reimbursement
Remicade
biosimilars
Janssen
Inflectra
Pfizer
Renflexis
Merck
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright
Motley Fool
Sun, 09/17/17 - 09:56 am
JNJ
Remicade
Stelara
drug pricing
Imbruvica
Xarelto
Darzalex
devices
consumer health
FDA Form 483 for Celltrion May Offer a Glimpse Into Limited Uptake for Remicade Biosimilar
RAPS.org
Fri, 09/8/17 - 09:28 am
FDA
Celltrion
biosimilars
Pfizer
Inflectra
Remicade
Remicade Is a Litmus Test for PBMs
Bloomberg
Fri, 08/18/17 - 12:04 am
Remicade
PBMs
biosimilars
CVS Health
Express Scripts
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
patents
AbbVie
Humira
Pfizer
Lipitor
Norvasc
GSK
Advair
Sanofi
Lantus
JNJ
Remicade
AstraZeneca
Crestor
Nexium
Amgen
Neulasta
Novartis
Diovan
Merck undercuts Pfizer on Remicade biosimilar price
BioPharma Dive
Wed, 07/26/17 - 10:18 pm
Merck
Pfizer
Remicade
drug pricing
biosimilars
Renflexis
JNJ

Pages